FDA Warning Letter — Changzhou Qianhong Biopharma Co., Ltd.
The FDA took a Warning Letter action against Changzhou Qianhong Biopharma Co., Ltd. on June 10, 2013 (Changzhou, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Changzhou Qianhong Biopharma Co., Ltd.
- Date
- June 10, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Center
- CDER
- Location
- Changzhou (China)